RSS   Newsletter   Contact   Advertise with us
Post Online Media

Kura Oncology names Steven Stein to board of directors

Steven H. SteinKura Oncology, Inc., a clinical stage biopharmaceutical company, announced the appointment of Steven H. Stein to its board of directors.

Dr. Stein currently serves as Executive Vice President and Chief Medical Officer of Incyte Corporation.

Previously, Dr. Stein worked for Novartis Pharmaceuticals Corporation, where he most recently served as Senior Vice President, U.S. Clinical Development & Medical Affairs at Novartis Oncology U.S.

Prior to Novartis, Dr. Stein worked at GlaxoSmithKline as Vice President, Global Oncology, Clinical Development and also as Head of Medicines Development for Hematology and Supportive Care.

He earned his M.D. from the University of Witwatersrand in Johannesburg, South Africa.


 LATEST MOVES FROM California 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy